Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), affects millions globally, causing persistent symptoms like fatigue, brain fog, and chronic inflammation long after the acute infection resolves. As of 2025, the medical community continues to explore effective treatments. Among emerging options, Ivermectin, an antiparasitic agent traditionally used for...